What is IMDX's other commercial liabilities?

IMDX (IMDX) reported other commercial liabilities of $3.33M in Q1 2026.

How has IMDX's other commercial liabilities changed year-over-year?

IMDX's other commercial liabilities increased by 32.1% year-over-year, from $2.52M to $3.33M.

What is the long-term trend for IMDX's other commercial liabilities?

Over 5 years (2020 to 2025), IMDX's other commercial liabilities has grown at a -6.6% compound annual growth rate (CAGR), from $3.47M to $2.46M.

IMDX IMDX Other Commercial Liabilities

Other Commercial Liabilities at other companies

Guardant HealthGH

——

Fulgent Genetics, Inc.FLGT

——

GeneDx HoldingsWGS

——

VeracyteVCYT

——

Other financials

Income statement

See full

Revenue$32.0K-98.5%

Gross profit$15.0K-98.9%

Operating income-$4.4M+35.1%

Net income-$4.3M+35.7%

EPS (diluted)-$0.12+53.8%

Balance sheet

See full

Cash & equivalents$28.2M-9.1%

Total debt$2.9M-13.5%

Total equity-$10.7M-205%

Total assets$40.4M-33.0%

Cash flow

See full

Operating cash flow-$7.6M-30.8%

CapEx$613.0K+99.7%

Free cash flow-$8.3M-34.3%

Valuation

See full

Market cap$185.35M+92.3%

Enterprise value$160.03M+113%

P/S95.1×+72.5×

Profitability

See full

Gross margin51.3%-3.0pp

Operating margin-2,500.7%+4,459pp

Net margin-2,454.6%+4,017pp

FCF margin-1,409.7%-6,023pp

Returns & leverage

See full

Return on equity-532.9%-717pp

Debt / equity2.9×+2.8×

Current ratio2.5×-1.2×

Where this comes from

Reported directly by IMDX in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: IMDX’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about IMDX's other commercial liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is IMDX's other commercial liabilities?: IMDX (IMDX) reported other commercial liabilities of $3.33M in Q1 2026.
How has IMDX's other commercial liabilities changed year-over-year?: IMDX's other commercial liabilities increased by 32.1% year-over-year, from $2.52M to $3.33M.
What is the long-term trend for IMDX's other commercial liabilities?: Over 5 years (2020 to 2025), IMDX's other commercial liabilities has grown at a -6.6% compound annual growth rate (CAGR), from $3.47M to $2.46M.